Cardiac Metabolism and Diffusion
Traditional Poster
Cardiovascular
Monday, 11 May 2026
This session will showcase emerging cardiac metabolism and diffusion imaging techniques.
Skill Level: Intermediate,Advanced
|
370-05-037.
Comparative Evaluation of 3D TFE UTE and 3D FLORET UTE in Sodium MRI for Myocardial Imaging at 3T
Impact: Provides guidance to MR researchers and clinicians
on selecting sodium MRI strategies for myocardial imaging, enabling more
efficient design of future in vivo sodium cardiac studies.
|
||
|
370-05-038.
Myocardial Mapping of glucose metabolism with Multi-echo 2H bSSFP: Pilot study in humans on a clinical 3T MRI scanner
Impact: The first study of
human cardiac DMI at 3T was performed using multi-echo bSSFP, showing
capability to isolate deuterated water and glucose in a 10-min scan, and advantage
of SNR over multi-echo GRE and MRSI within the same scan time.
|
||
|
370-05-039.
Free-breathing Cardiac Proton Spectroscopy at 7T
Impact: Combining free-breathing navigator gating with phase-cycling reduces motion artefacts, preserves voxel alignment, and stabilises metabolite quantification of cardiac MRS at 7T. Higher metabolic SNR and fewer spurious signals enhances measurement sensitivity.
|
||
|
370-05-040.
The value of non-contrast cardiac magnetic resonance T1ρ mapping in assessing myocardial fibrosis in HCM and DCM
Impact: This study provides a safer, contrast-agent-free method for diagnosing HCM and DCM and assessing myocardial injury, which helps broaden the patient population eligible for examination while offering a new approach for clinical monitoring of disease progression and prognosis evaluation.
|
||
|
370-05-041.
Towards intermediate-diffusion-time cardiac diffusion-tensor imaging, with a motion-compensated stimulated echo acquisition
Impact: Existing techniques cannot acquire diffusion data in the myocardium with diffusion times on the order of 100 ms, where time dependence of clinically relevant diffusion parameters is observed. This work proposes motion-compensated STEAM as a possible direction to address this.
|
||
|
370-05-042.
Closing the Gap: Combined Functional and Metabolic Cardiac MRI in Companion Animals
Impact: By acquiring both functional and metabolic data in one session, our approach enables noninvasive myocardial bioenergetic assessments. This will inform clinicians and researcher, both human and animal alike, about disease characterization and therapeutic monitoring.
|
||
|
370-05-043.
MRI Assessment of Antihistamine Effects on No-Reflow Phenomenon Following Myocardial Infarction
Impact: We provide initial evidence
that mast cell degranulation/histamine release plays a key role in no-reflow
phenomenon after myocardial infarction; and that no-reflow can be prevented
using over-the-counter loratadine prophylaxis.
|
||
|
370-05-044.
CMR-FT to assess the mediation effect of amino acid metabolism on left myocardial damage in obese individuals
Impact: Our findings on
the effect of amino acids metabolism
and obesity
on left myocardial function provide a basis for clinical management and
treatment of comorbidities.
|
||
|
370-05-045.
Assessing the impact of fiber orientation from DTI in myocardial passive stiffness estimation
Impact: This study contributes
to better understanding of fiber orientation impact, and help select an
appropriate implementation method. It represents a key step toward improving
the clinical effectiveness of myocardial stiffness as a biomarker for the early
detection of heart failure.
|